Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
7.99
+0.01 (0.13%)
Jul 3, 2025, 1:00 PM - Market closed
Vigil Neuroscience Market Cap
Vigil Neuroscience has a market cap or net worth of $380.94 million as of July 3, 2025. Its market cap has increased by 139.04% in one year.
Market Cap
380.94M
Enterprise Value
306.53M
1-Year Change
139.04%
Ranking
Category
Stock Price
$7.99
Market Cap Chart
Since the IPO on January 7, 2022, Vigil Neuroscience's market cap has decreased from $395.70M to $380.94M, a decrease of -3.73%. That is a compound annual growth rate of -1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 380.94M | 448.76% |
| Dec 31, 2024 | 69.42M | -42.76% |
| Dec 29, 2023 | 121.27M | -72.73% |
| Dec 30, 2022 | 444.76M | 12.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |